Cargando…
Possible clinical effects of molecular hydrogen (H(2)) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation
BACKGROUND AND AIM: It is supposed that enhanced oxidative stress and inflammation are involved with the poor clinical outcomes in patients on chronic dialysis treatment. Recent studies have shown that molecular hydrogen (H(2)) is biologically active as an anti-inflammatory agent. Thus, we developed...
Autores principales: | Nakayama, Masaaki, Itami, Noritomo, Suzuki, Hodaka, Hamada, Hiromi, Osaka, Naoyuki, Yamamoto, Ryo, Tsunoda, Kazumasa, Nakano, Hirofumi, Watanabe, Kimio, Zhu, Wan-Jun, Maruyama, Yukio, Terawaki, Hiroyuki, Kabayama, Shigeru, Nakazawa, Ryoichi, Miyazaki, Mariko, Ito, Sadayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597210/ https://www.ncbi.nlm.nih.gov/pubmed/28902900 http://dx.doi.org/10.1371/journal.pone.0184535 |
Ejemplares similares
-
Novel haemodialysis (HD) treatment employing molecular hydrogen (H(2))-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study
por: Nakayama, Masaaki, et al.
Publicado: (2018) -
Amelioration of cardio-renal injury with aging in dahl salt-sensitive rats by H(2)-enriched electrolyzed water
por: Zhu, Wan-Jun, et al.
Publicado: (2013) -
Dissolved molecular hydrogen (H(2)) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity
por: Nakayama, Masaaki, et al.
Publicado: (2017) -
Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study
por: Watanabe, Kimio, et al.
Publicado: (2021) -
Comparisons of fatigue between dialysis modalities: A cross-sectional study
por: Maruyama, Yukio, et al.
Publicado: (2021)